Type 2 diabetes prevention in the “real world”: Three-year results of the GOAL implementation trial
- Pilvikki Absetz, PhD (pilvikki.absetz{at}thl.fi),
- Brian Oldenburg, PhD,
- Nelli Hankonen, MSocSci,
- Raisa Valve, PhD,
- Heikki Heinonen, PhD,
- Aulikki Nissinen, MD, PhD,
- Mikael Fogelholm, ScD,
- Martti Talja, MD, PhD and
- Antti Uutela, PhD
- National Institute for Health and Welfare, Finland
- Monash University, Australia
- University of Helsinki, Finland
- Academy of Finland, Finland
- Päijät-Häme Central Hospital, Finland
Abstract
Objective: We study the effectiveness of the GOAL Lifestyle Implementation Trial at 36-month follow-up.
Research Design and Methods: Participants (N = 352, FINDRISC = 16.2 ± 3.3, BMI 32.6 ± 5.0) received six lifestyle counseling sessions over eight months. Measurements were at baseline, 12 months (88.6%) and at 36 months (77.0%).
Results: Statistically significant risk reduction at 12 months was maintained at 36 months in weight (−1.0 ± 5.6 kg), BMI (−0.5 ± 2.1), and serum total cholesterol (−0.4 ± 1.1 mmol/l).
Conclusions: Maintenance of risk reduction in this “real world” trial proves the intervention's potential for significant public health impact.
Footnotes
-
- Received January 9, 2009.
- Accepted April 23, 2009.
- Copyright © American Diabetes Association
